Literature DB >> 8147820

Field stimulation-induced noradrenaline release from guinea-pig atria is modulated by prejunctional alpha 2-adrenoceptors and protein kinase C.

H Brasch1.   

Abstract

Guinea-pig left atria were loaded with 10 microCi 7-[3H]noradrenaline, and noradrenaline release from sympathetic nerve endings was then elicited by refractory period field stimulation. When one pulse of 0.2 ms duration was applied during each refractory period, the resulting transmitter release was halved by 3 x 10(-7) mol/l of the alpha 2-adrenoceptor agonist clonidine and increased about 2.5-fold by either 3 x 10(-7) mol/l of the alpha 2-adrenoceptor antagonist idazoxan, 5 x 10(-3) mol/l of the potassium channel blocker tetraethylammonium chloride (TEA) or 3 x 10(-7) mol/l phorbol-12-myristate-13-acetate (PMA), an activator of protein kinase C (PKC). Phorbol-12-myristate-13-acetate-4-O-methylether, a compound which does not stimulate PKC, was ineffective. The stimulatory effect of PMA was antagonized by 7 x 10(-5) mol/l of the PKC inhibitor polymyxin B. No significant transmitter release was observed when either PMA or TEA was applied together with 10(-7) mol/l of the sodium channel blocker tetrodotoxin. Combinations of either idazoxan and TEA or PMA and TEA caused greater increases of the noradrenaline release than any individual drug given alone. Thus, different mechanisms of action seem to mediate the increase of noradrenaline release by action potential prolongation on the hand and activation of PKC or inhibition of alpha 2-adrenoceptors on the other hand. In contrast, the effects of idazoxan and PMA were not additive, which suggests a common mechanism of action. In atria pretreated for 10 min with 10(-4) mol/l N-ethylmaleimide, an alkylating agent which inactivates Gi-proteins neither idazoxan nor PMA caused a significant increase of the stimulation-induced transmitter release, while TEA was still effective. When a train of four pulses, lasting 0.05 ms each, was applied during each refractory period, the resulting transmitter release was not modified by idazoxan or PMA, but was significantly increased by TEA. From these results, a scheme is proposed which links the regulation of noradrenaline release by prejunctional alpha 2-adrenoceptors and protein kinase C via an influence on a common inhibitory Gi-protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8147820     DOI: 10.1007/bf00788873

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  27 in total

1.  Alpha-adrenergic inhibition of sympathetic neurotransmitter release mediated by modulation of N-type calcium-channel gating.

Authors:  D Lipscombe; S Kongsamut; R W Tsien
Journal:  Nature       Date:  1989-08-24       Impact factor: 49.962

2.  Role of calcium channels and protein kinase C for release of norepinephrine and neuropeptide Y.

Authors:  M Haass; C Förster; G Richardt; R Kranzhöfer; A Schömig
Journal:  Am J Physiol       Date:  1990-11

3.  Prejunctional beta-adrenoceptors, angiotensin II and neuropeptide Y receptors on sympathetic nerves in mouse atria are linked to N-ethylmaleimide-susceptible G-proteins.

Authors:  S Foucart; T V Murphy; H Majewski
Journal:  J Auton Nerv Syst       Date:  1990-07

4.  Role of auto-inhibitory feed-back in cardiac sympathetic transmission assessed by simultaneous measurements of changes in 3H-efflux and atrial rate in guinea-pig atrium.

Authors:  J A Angus; A Bobik; G P Jackman; I J Kopin; P I Korner
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

5.  Effects of the cardiotonic drug ARL-115 on the release of noradrenaline from the cat atrium, the binding of 3H-ouabain to plasma membranes and the movements of calcium in mitochondria.

Authors:  V Ceña; J Frias; A G García; M C Molinos; G P Nicolás; P Sánchez-García
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-09       Impact factor: 3.000

6.  Enhancement of noradrenaline release by 12-O-tetradecanoyl phorbol-13-acetate, an activator of protein kinase C.

Authors:  C Allgaier; O Von Kügelgen; G Hertting
Journal:  Eur J Pharmacol       Date:  1986-10-07       Impact factor: 4.432

7.  The influence of activation or inhibition of protein kinase C on the release of radioactivity from rat isolated atria labelled with [3H]-noradrenaline.

Authors:  E J Ishac; A De Luca
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

8.  Effect of phorbol ester and pertussis toxin on the enhancement of noradrenaline release by angiotensin II in mouse atria.

Authors:  I F Musgrave; H Majewski
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

9.  Activation of protein kinase C potentiates norepinephrine release from sinus node.

Authors:  H Shuntoh; C Tanaka
Journal:  Am J Physiol       Date:  1986-12

10.  On electrophysiological responses to phorbol esters which stimulate protein kinase C in rabbit sino-atrial node cells.

Authors:  H Satoh; K Hashimoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-03       Impact factor: 3.000

View more
  2 in total

1.  Enhancement of noradrenaline release by angiotensin II and bradykinin in mouse atria: evidence for cross-talk between G(q/11) protein- and G(i/o) protein-coupled receptors.

Authors:  S L Cox; V Schelb; A U Trendelenburg; K Starke
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

Review 2.  The regulation of neurotransmitter secretion by protein kinase C.

Authors:  P F Vaughan; J H Walker; C Peers
Journal:  Mol Neurobiol       Date:  1998-10       Impact factor: 5.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.